Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Part of paid clinical trials in Beverly Hills, California.
- Sponsor
- FemPulse Corporation
- Study ID
- NCT07195656
- Status
- Recruiting
Conditions
- Overactive Bladder (OAB)
Eligibility Criteria
- Sex
- FEMALE
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Device Group — DEVICEnon-implanted, vaginal electrical stimulation device
- Medication Group — DRUGOAB Medication
Study Details
A study to evaluate the safety and effectiveness of FemPulse System
Key Dates
- Start date
- Sep 30, 2025
- Status verified
- Sep 2025
- Primary completion
- May 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 151 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Device GroupSubjects receiving the FemPulse System
- Other: Medication GroupSubjects receiving medication
Primary Outcome Measure
Mean Change in Voids per Day [ Time Frame: 6 months ]
Central Contacts
- Monica Unger7275123718
Locations (15)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cedars Sinai | Beverly Hills | California | 90211 | Karyn Eilber, MD (PRINCIPAL_INVESTIGATOR) |
| UCLA | Los Angeles | California | 90095 | Nassura Richard 310-267-4331 A Lenore Ackerman, MD (PRINCIPAL_INVESTIGATOR) |
| UC Irvine | Orange | California | 92868 | Bryan Robles 714-509-6130 Olivia Chang, MD (PRINCIPAL_INVESTIGATOR) |
| Stanford | Palo Alto | California | 94304 | Kathryn Batham 650-724-7826 Eric Sokol, MD (PRINCIPAL_INVESTIGATOR) |
| USCD | San Diego | California | 92037 | Melissa Saurez 858-249-4447 Yahir Santiago-Lastra, MD (PRINCIPAL_INVESTIGATOR) |
| Holy Cross Medical Group - Women's Center | Fort Lauderdale | Florida | 33334 | Judie Corbett 954-542-4841 Guillermo Davila, MD (PRINCIPAL_INVESTIGATOR) |
| Comprehensive Urologic | Barrington | Illinois | 60010 | Sunny Sian 847-852-1777 Tamra Lewis, MD (PRINCIPAL_INVESTIGATOR) |
| University of Louisville | Louisville | Kentucky | 40205 | Decora Whalen 502-588-4412 Sean Francis, MD (PRINCIPAL_INVESTIGATOR) |
| Chesapeake Urology | Owings Mills | Maryland | 21117 | Seema Shahi 410-616-8431 Laura Giusto, MD (PRINCIPAL_INVESTIGATOR) |
| Minnesota Urology | Woodbury | Minnesota | 55125 | Carrie McKenzie 651-999-6903 Jodi Michaels, MD (PRINCIPAL_INVESTIGATOR) |
| Adult & Pediatric Urology | Omaha | Nebraska | 68114 | Peyton Schneider 402-399-7898 Rebecca McCrery, MD (PRINCIPAL_INVESTIGATOR) |
| Atrium Health | Charlotte | North Carolina | 28204 | Robbin Clark 704-355-7466 Michael Kennelly, MD (PRINCIPAL_INVESTIGATOR) |
| Southern Urogynecology | West Columbia | South Carolina | 29169 | Tina McCready 803-457-7000 Andrea Pezzella, MD (PRINCIPAL_INVESTIGATOR) |
| Sanford Health | Sioux Falls | South Dakota | 57105 | Jennifer Pratt 605-328-1391 Kevin Benson, MD (PRINCIPAL_INVESTIGATOR) |
| INOVA | Falls Church | Virginia | 22042 | Claudia Lovo-Alvarez 703-776-4600 Abbas Shobeiri, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Beverly Hills, CA
Related Studies
- PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OABRecruiting · Axonics, Inc. · Chicago, Illinois
- APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in WomenRecruiting · Medstar Health Research Institute · Birmingham, Alabama
- Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder FunctionRecruiting · Northwestern University · Chicago, Illinois
- Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in WomenRecruiting · InMode MD Ltd. · Palo Alto, California